Without studies that separate trans men from cis women, the disparity will continue.
The Conference on Retroviruses and Opportunistic Infections revealed both promising, and concerning, study results.
The latest scientific trials show the reality of a safe-effective male birth control pill is closer than ever.
The HIV prevention drug still carries a heavy stigma among people of color.
Researchers from New York’s Aaron Diamond AIDS Research Center presented a new long-lasting PrEP pill at the 25th Conference on Retroviruses and Opportunistic Infections (CROI).
A question many of us ponder daily.
A controversial case has launched a state investigation of discriminatory and unethical insurance practices.